MicroRNA-mediated immune modulation as a therapeutic strategy in host-implant integration.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Advanced Drug Delivery Reviews

• Publication date

  2015-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.addr.2015.05.013PMID 26024977
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preclinical and clinical development of siRNA-based therapeutics.

  2015cited by this paper
• Role of high shear rate in thrombosis.

  2015cited by this paper
• The role of microRNAs in the control and mechanism of action of IL-10.

  2014cited by this paper
• Lentivirus delivery of IL‐10 to promote and sustain macrophage polarization towards an anti‐inflammatory phenotype

  2014cited by this paper
• MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation.

  2014cited by this paper
• Sustained delivery of proangiogenic microRNA‐132 by nanoparticle transfection improves endothelial cell transplantation

  2014cited by this paper
• Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement

  2014cited by this paper
• Spine Interbody Implants: Material Selection and Modification, Functionalization and Bioactivation of Surfaces to Improve Osseointegration

  2014cited by this paper
• Regenerative medicine in orthopedics using cells, scaffold, and microRNA

  2014cited by this paper
• Bioactive Coatings for Orthopaedic Implants—Recent Trends in Development of Implant Coatings

  2014cited by this paper
• Development of microRNA therapeutics is coming of age

  2014cited by this paper
• The M1 and M2 paradigm of macrophage activation: time for reassessment

  2014cited by this paper
• Host miR-26a suppresses replication of porcine reproductive and respiratory syndrome virus by upregulating type I interferons

  2014cited by this paper
• Focal Controlled Drug Delivery

  2014cited by this paper
• miR-27a Regulates Inflammatory Response of Macrophages by Targeting IL-10

  2014cited by this paper
• Engulfment of Apoptotic Cells by Macrophages: A Role of MicroRNA-21 in the Resolution of Wound Inflammation

  2014cited by this paper
• MicroRNAs: New Regulators of Toll-Like Receptor Signalling Pathways

  2014cited by this paper
• MicroRNA let-7c Regulates Macrophage Polarization

  2013cited by this paper
• Developing siRNA therapies to address osteoporosis.

  2013cited by this paper
• Non-viral gene-activated matrices

  2013cited by this paper
• MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease.

  2013cited by this paper
• Drug delivery from hydroxyapatite-coated titanium surfaces using biodegradable particle carriers.

  2013cited by this paper
• Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium.

  2013cited by this paper
• Bone response to the multilayer BMP-2 gene coated porous titanium implant surface.

  2013cited by this paper
• Macrophages-Key cells in the response to wear debris from joint replacements.

  2013cited by this paper
• The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a.

  2013cited by this paper
• First microRNA mimic enters clinic

  2013cited by this paper
• MicroRNA-based therapy in pain medicine: Current progress and future prospects.

  2013cited by this paper
• Polyethylenimines for siRNA and miRNA delivery in vivo.

  2013cited by this paper
• High levels of ephrinB2 over-expression increases the osteogenic differentiation of human mesenchymal stem cells and promotes enhanced cell mediated mineralisation in a polyethyleneimine-ephrinB2 gene-activated matrix.

  2013cited by this paper
• Transition of a microRNA from Repressing to Activating Translation Depending on the Extent of Base Pairing with the Target

  2013cited by this paper
• The future of biologic coatings for orthopaedic implants.

  2013cited by this paper
• RNAi in clinical studies.

  2013cited by this paper
• MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2.

  2013cited by this paper
• Type I IFN Inhibits Innate IL-10 Production in Macrophages through Histone Deacetylase 11 by Downregulating MicroRNA-145

  2013cited by this paper
• MicroRNA-92a Negatively Regulates Toll-like Receptor (TLR)-triggered Inflammatory Response in Macrophages by Targeting MKK4 Kinase*

  2013cited by this paper
• Inhibitory effects of recombinant IL-4 and recombinant IL-13 on UHMWPE-induced bone destruction in the murine air pouch model.

  2013cited by this paper
• The response of macrophages to titanium particles is determined by macrophage polarization.

  2013cited by this paper
• Evidence for miR‐181 involvement in neuroinflammatory responses of astrocytes

  2013cited by this paper
• Progress in microRNA delivery.

  2013cited by this paper
• Negative regulation of Toll-like receptor 4 signaling by IL-10–dependent microRNA-146b

  2013cited by this paper
• High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics.

  2013cited by this paper
• Good things come in small packages

  2012cited by this paper
• MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

  2012cited by this paper
• Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials.

  2012cited by this paper
• Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response.

  2012cited by this paper
• Argonaute 2 Complexes Selectively Protect the Circulating MicroRNAs in Cell-Secreted Microvesicles

  2012cited by this paper
• Organ repair and regeneration: an overview.

  2012cited by this paper
• Drug delivery from titanium surface using biodegradable nanoparticle carriers

  2012cited by this paper
• Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

  2012cited by this paper
• Revision joint replacement, wear particles, and macrophage polarization.

  2012cited by this paper
• Lipid-based carriers of microRNAs and intercellular communication

  2012cited by this paper
• MicroRNAs in Common Human Diseases

  2012cited by this paper
• Synthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivity.

  2012cited by this paper
• NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223

  2012cited by this paper
• miRNA‐125b regulates TNF‐α production in CD14+ neonatal monocytes via post‐transcriptional regulation

  2012cited by this paper
• Regulation of Macrophage Polarization and Wound Healing

  2012cited by this paper
• Localized Delivery of Dexamethasone from Electrospun Fibers Reduces the Foreign Body Response

  2012cited by this paper
• Inducible MicroRNA-223 Down-Regulation Promotes TLR-Triggered IL-6 and IL-1β Production in Macrophages by Targeting STAT3

  2012cited by this paper
• Gene-activated and cell-migration guiding PEG matrices based on three dimensional patterning of RGD peptides and DNA complexes.

  2012cited by this paper
• Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials.

  2012cited by this paper
• Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2

  2012cited by this paper
• TLR2 Expression Is Regulated by MicroRNA miR-19 in Rheumatoid Fibroblast-like Synoviocytes

  2012cited by this paper
• Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes.

  2012cited by this paper
• Cutting Edge: MicroRNA Regulation of Macrophage Fusion into Multinucleated Giant Cells

  2012cited by this paper
• MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles

  2012cited by this paper
• The Therapeutic Potential of MicroRNAs in Cancer

  2012cited by this paper
• Engineering biomaterials to integrate and heal: The biocompatibility paradigm shifts

  2012cited by this paper
• Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine.

  2012cited by this paper
• This information is current as Production β Inflammasome and IL-1 miR-BART 15 Regulate the NLRP 3 Cutting Edge : miR-223 and EBV

  2012cited by this paper
• What's next? Alternative materials for articulation in total joint replacement.

  2012cited by this paper
• IL-10–induced microRNA-187 negatively regulates TNF-α, IL-6, and IL-12p40 production in TLR4-stimulated monocytes

  2012cited by this paper
• miR-451 Regulates Dendritic Cell Cytokine Responses to Influenza Infection

  2012cited by this paper
• Identifying Functional MicroRNAs in Macrophages with Polarized Phenotypes*

  2012cited by this paper
• Inhibition of biomaterial‐induced complement activation attenuates the inflammatory host response to implantation

  2012cited by this paper
• MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins

  2011cited by this paper
• Transplantation of Human Pericyte Progenitor Cells Improves the Repair of Infarcted Heart Through Activation of an Angiogenic Program Involving Micro-RNA-132

  2011cited by this paper
• Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice

  2011cited by this paper
• Subcellular Fate and Off-Target Effects of siRNA, shRNA, and miRNA

  2011cited by this paper
• Fabrication, characterization, and biological assessment of multilayer DNA coatings on sandblasted-dual acid etched titanium surface.

  2011cited by this paper
• MicroRNA‐146a regulates both transcription silencing and translation disruption of TNF‐α during TLR4‐induced gene reprogramming

  2011cited by this paper
• Lessons from innovation in drug-device combination products.

  2011cited by this paper
• MicroRNA‐98 negatively regulates IL‐10 production and endotoxin tolerance in macrophages after LPS stimulation

  2011cited by this paper
• Biomechanics of the Sensor-Tissue Interface—Effects of Motion, Pressure, and Design on Sensor Performance and the Foreign Body Response—Part I: Theoretical Framework

  2011cited by this paper
• Biocompatibility of implants: lymphocyte/macrophage interactions

  2011cited by this paper
• Spatiotemporal effects of a controlled-release anti-inflammatory drug on the cellular dynamics of host response.

  2011cited by this paper
• Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants.

  2011cited by this paper
• The Biocompatibility Manifesto: Biocompatibility for the Twenty-first Century

  2011cited by this paper
• Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles.

  2011cited by this paper
• Selective Upregulation of microRNA Expression in Peripheral Blood Leukocytes in IL-10−/− Mice Precedes Expression in the Colon

  2011cited by this paper
• Macrophage and dendritic cell phenotypic diversity in the context of biomaterials.

  2011cited by this paper
• MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease

  2011cited by this paper
• MicroRNA therapeutics

  2011cited by this paper
• Quantifying the effect of pore size and surface treatment on epidermal incorporation into percutaneously implanted sphere-templated porous biomaterials in mice.

  2011cited by this paper
• Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice.

  2011cited by this paper
• Developing therapeutic microRNAs for cancer

  2011cited by this paper
• Mediators of the inflammatory response to joint replacement devices

  2011cited by this paper
• Current progress of siRNA/shRNA therapeutics in clinical trials

  2011cited by this paper
• Chemical modification and design of anti-miRNA oligonucleotides

  2011cited by this paper
• Tissue engineering tools for modulation of the immune response.

  2011cited by this paper

• MMP-9 Expression in bone cells in the developing femur.

  2025cites this paper
• The epigenetic landscape of rheumatoid arthritis: Pathogenesis and drug therapeutic potentials

  2025cites this paper
• Dual effects of bisphosphonates on bone metabolism and implant osseointegration: mechanisms, risks and clinical strategies.

  2025cites this paper
• Exosomal miRNAs involvement in pathogenesis, diagnosis, and treatment of rheumatoid arthritis

  2025cites this paper
• Phosphorene: A novel nanomaterial revolutionizing biomedicine

  2024cites this paper
• Alterations in Small Non-coding MicroRNAs (miRNAs) and the Potential Role in the Development of Aseptic Loosening After Total Hip Replacement: Study Protocol for an Observational, Cross-Sectional Study

  2024cites this paper
• Research Progress on lncRNA BLACAT1 in Pharyngeal Squamous Cell Carcinoma

  2024cites this paper
• Comprehensive overview of microRNA function in rheumatoid arthritis

  2023cites this paper
• Immunoregulatory silicon-deposited implant promotes osseointegration

  2023cites this paper
• Enhancing bone regeneration with a novel bioactive glass-functionalized polyetheretherketone scaffold by regulating the immune microenvironment

  2023cites this paper
• Scope of 2D materials for immune response-a review

  2022cites this paper
• In Vivo Comparison of Synthetic Macroporous Filamentous and Sponge-like Skin Substitute Matrices Reveals Morphometric Features of the Foreign Body Reaction According to 3D Biomaterial Designs

  2022cites this paper
• Bioactive Coatings With Anti-osteoclast Therapeutic Agents for Bone Implants: Enhanced Compliance and Prolonged Implant Life.

  2022cites this paper
• photonics Changes in Spectral Fluorescence Properties of a Near-Infrared Photosensitizer in a Nanoform as a Coating of an Optical Fiber Neuroport

  2021cites this paper
• Macrophage Polarization in Response to Biomaterials for Vascularization

  2021cites this paper
• Long non-coding RNA BLACAT1, a novel promising biomarker and regulator of human cancers.

  2020cites this paper
• Black phosphorus-based 2D materials for bone therapy

  2020cites this paper
• Macrophage and Fibroblast Interactions in Biomaterial‐Mediated Fibrosis

  2019cites this paper
• Tailoring the immuno-responsiveness of anodized nano-engineered titanium implants.

  2018cites this paper
• Invasive Intraneural Interfaces: Foreign Body Reaction Issues

  2017cites this paper
• Delivery strategies to control inflammatory response: Modulating M1-M2 polarization in tissue engineering applications.

  2016cites this paper
• Magnet-Bead Based MicroRNA Delivery System to Modify CD133+ Stem Cells

  2016cites this paper
• MicroRNAs in liver tissue engineering - New promises for failing organs.

  2015cites this paper